Clinigen Group (CLIN)

 

Latest News

Total Voting Rights

RNS Number: 9389Z Clinigen Group plc 29 December 2017 29 December 2017 Clinigen Group plc ("Clinigen" or the "Group") Total Voting Rights and Capital In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Group notifies the market that as at 29 December 2017 Clinigen's issued share capital consists of 122,286,083 ordinary shares...

Clinigen director steps down

Clinigen Group director Chris Rigg has resigned with immediate effect to seek a chief executive role elsewhere. Clinigen CE...

Directorate Change

RNS Number: 4871Y Clinigen Group plc 06 December 2017 6 December 2017 Directorate Change Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere. Shaun Chilton, CEO of Clinigen, said: "On behalf of the B...

Clinigen in equity issue

Clinigen Group issued 17,925 ordinary shares yesterday to satisfy share options vesting under the group's all staff long term...

All News

DateHeadlineSource
29-12-17Total Voting RightsRNS
06-12-17Clinigen director steps down StockMarketWire
06-12-17Directorate ChangeRNS
05-12-17Clinigen in equity issue StockMarketWire
04-12-17Issue of EquityRNS
30-11-17Total Voting RightsRNS
29-11-17Broker Forecast - N+1 Singer issues a broker note on Clinigen GroupStockMarketWire
28-11-17All resolutions passed at AGM of ClinigenStockMarketWire
28-11-17Result of AGMRNS
24-11-17Director Deals - Clinigen Group (CLIN)StockMarketWire
24-11-17Director/PDMR ShareholdingRNS
20-11-17Clinigen issues sharesStockMarketWire
20-11-17Issue of EquityRNS
20-11-17Clinigen remuneration policy to be put at AGMStockMarketWire
17-11-17AGM ResolutionsRNS
10-11-17Form 8.3 - Clinigen Group PLCRNS
10-11-17Clinigen options exercised StockMarketWire
10-11-17Issue of EquityRNS
07-11-17Grant of share optionsRNS
07-11-17Form 8.3 - Clinigen Group plcRNS
02-11-17Form 8.3 - Clinigen Group plcRNS
02-11-17Form 8.3 - Clinigen Group plcRNS
02-11-17Form 8.3 - Clinigen Group PlcRNS
02-11-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
02-11-17Admission of Consideration SharesRNS
01-11-17Director/PDMR ShareholdingRNS
01-11-17Form 8.3 - Clinigen Group plcRNS
01-11-17Form 8.3 - Clinigen Group PlcRNS
01-11-17Board changes at ClinigenStockMarketWire
01-11-17Quantum, Clinigen deal effectiveStockMarketWire
01-11-17Form 8.3 - Clinigen Group PLCRNS
01-11-17Board changesRNS
01-11-17Form 8.3 - Clinigen Group PlcRNS
01-11-17Scheme of Arrangement becomes EffectiveRNS
01-11-17Broker Forecast - Berenberg issues a broker note on Clinigen GroupStockMarketWire
01-11-17Form 8.3 - Clinigen Group PlcRNS
01-11-17Form 8.3 - Clinigen Group plcRNS
01-11-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
31-10-17Form 8.3 - CLIN LN/QP LNRNS
31-10-17Form 8.3 - QP LN/CLIN LNRNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account